Search research articles
Contact Us
Filters
Showing results (71-80 of 189) with videos related to
Page
of 19
Sort By:
BMC Medical Genomics
|
December 31, 2015
Profound impact of sample processing delay on gene expression of multiple myeloma plasma cells
Tobias Meißner, Anja Seckinger, Kari Hemminki, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 2, 2022
Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis
Inge Oudaert, Hatice Satilmis, Philip Vlummens, et al.
Haematologica
|
November 22, 2011
Genes with a spike expression are clustered in chromosome (sub)bands and spike (sub)bands have a powerful prognostic value in patients with multiple myeloma
Alboukadel Kassambara, Dirk Hose, Jérôme Moreaux, et al.
Oncotarget
|
October 17, 2015
miRNAs in multiple myeloma--a survival relevant complex regulator of gene expression
Anja Seckinger, Tobias Meißner, Jérôme Moreaux, et al.
Oncotarget
|
February 12, 2015
In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma
Ken Maes, Eva De Smedt, Alboukadel Kassambara, et al.
Journal of Medical Economics
|
November 8, 2022
Systematic literature review of health economic models developed for multiple myeloma to support future analyses
Mimi Choon-Quinones, Tamás Zelei, Bertalan Németh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 2015
Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimens
Tilmann Bochtler, Ute Hegenbart, Christina Kunz, et al.
Leukemia
|
September 9, 2020
RFWD2 induces cellular proliferation and selective proteasome inhibitor resistance by mediating P27 ubiquitination in multiple myeloma
Chunyan Gu, Ting Lu, Wang Wang, et al.
Oncoimmunology
|
July 29, 2016
Lenalidomide enhances myeloma-specific T-cell responses in vivo and in vitro
Isabelle Krämer, Melanie Engelhardt, Sabrina Fichtner, et al.
Haematologica
|
October 17, 2009
Thymosin β4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma
Jo Caers, Dirk Hose, Ine Kuipers, et al.
Page
of 19
Search research articles
Search
Showing results (71-80 of 189) with videos related to
Sort By:
Page
of 19
BMC Medical Genomics
|
December 31, 2015
Profound impact of sample processing delay on gene expression of multiple myeloma plasma cells
Tobias Meißner, Anja Seckinger, Kari Hemminki, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 2, 2022
Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis
Inge Oudaert, Hatice Satilmis, Philip Vlummens, et al.
Haematologica
|
November 22, 2011
Genes with a spike expression are clustered in chromosome (sub)bands and spike (sub)bands have a powerful prognostic value in patients with multiple myeloma
Alboukadel Kassambara, Dirk Hose, Jérôme Moreaux, et al.
Oncotarget
|
October 17, 2015
miRNAs in multiple myeloma--a survival relevant complex regulator of gene expression
Anja Seckinger, Tobias Meißner, Jérôme Moreaux, et al.
Oncotarget
|
February 12, 2015
In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma
Ken Maes, Eva De Smedt, Alboukadel Kassambara, et al.
Journal of Medical Economics
|
November 8, 2022
Systematic literature review of health economic models developed for multiple myeloma to support future analyses
Mimi Choon-Quinones, Tamás Zelei, Bertalan Németh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 2015
Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimens
Tilmann Bochtler, Ute Hegenbart, Christina Kunz, et al.
Leukemia
|
September 9, 2020
RFWD2 induces cellular proliferation and selective proteasome inhibitor resistance by mediating P27 ubiquitination in multiple myeloma
Chunyan Gu, Ting Lu, Wang Wang, et al.
Oncoimmunology
|
July 29, 2016
Lenalidomide enhances myeloma-specific T-cell responses in vivo and in vitro
Isabelle Krämer, Melanie Engelhardt, Sabrina Fichtner, et al.
Haematologica
|
October 17, 2009
Thymosin β4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma
Jo Caers, Dirk Hose, Ine Kuipers, et al.
Page
of 19